SPECIAL NOTICE | Nesh is currently looking for registered psychologists to join the team at Strategic Psychology. See available positions

Listen on Apple Podcasts | Spotify | Google Podcasts | Stitcher

In this episode of Better Thinking, Nesh Nikolic speaks with Dr Eli Kotler about the use of psychedelics as a therapeutic aid to trauma and addiction.

Dr Eli Kotler is a consultant psychiatrist, holds an academic position at Monash University through the Alfred Psychiatry Research Centre, and is the medical director of Malvern Private Hospital, the first addiction hospital in Australia. He is a member of the Australasian Professional Society on Alcohol and other Drugs (APSAD). Clinically, Eli is interested in the deep connections between trauma and addiction and works within a neuro-psychoanalytic framework.

Dr Eli has overseen the development of a clinical program for addictions focused on trauma, particularly developmental trauma. This has led to an interest in medication-assisted trauma therapy. Eli worked for many years researching neurodegenerative diseases and was the principle investigator on numerous trials for novel therapeutics. He is founding member of the Melbourne Neuropsychoanalytic Group and welcomes new members. Through involvement with Monash University, Eli oversees the addiction rotation for medical students.

Dr Eli graduated from the first intake of the Certificate in Psychedelic-Assisted Therapies (CPAT) in June 2021. He has also been recently appointed as the Principal Investigator to lead Emyria’s upcoming MDMA trial.

Links:

Mind Medicine Australia (website)
Eli Kotler (email)

Connect with Nesh on: